Congress·In Committee·H.R. 2343

John W. Walsh Alpha-1 Home Infusion Act of 2025

Medicare Coverage for Alpha-1 Home Treatments

Mar 25, 2025·View on Congress.gov·Read full text

This bill is one vehicle in a longer effort. See the full story across every version.View effort →

Next up: A house committeeNo action in 15 months

This bill is sitting in the House Energy and Commerce and Ways and Means committees. It has not moved since March 2025, which means it has been stalled for about 15 months. The bill must receive a vote in these committees before it can move forward.

Legislative Progress

House

Senate

President

Law

Unlikely to pass

While the bill has support from both parties, most small healthcare bills struggle to pass on their own and usually need to be added to a larger year-end spending package.

How we got here

This bill’s path across every version that has carried it.

Reintroduced
Reintroduced from H.R. 4438 (118th), which died when its Congress ended.
H.R. 4438 (118th) →

Key Points

This bill would allow Medicare to pay for specialized treatments for Alpha-1 Antitrypsin Deficiency to be given in a patient's home. Right now, many people with this rare genetic condition must travel to a clinic or hospital every week to get their medicine through an IV.
The plan covers the cost of the medicine, the medical kits needed to give the infusion, and up to two hours of nursing care for each visit. This makes it much easier for patients who have trouble traveling due to lung or liver problems caused by the disorder.
To qualify, a person must be enrolled in Medicare Part B and be under the care of a doctor, nurse practitioner, or physician assistant. The coverage would pay for 80 percent of the costs, which is the same as most other Medicare outpatient services.
If the bill becomes law, these new benefits would officially begin on January 1, 2027. This delay gives the government time to set up the payment systems for the nurses and medical suppliers who will provide the care in people's homes.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.

Milestones

2 milestones2 actions

Mar 25, 2025House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.

Mar 25, 2025

Introduced in House

The bill was officially filed and given a number. It now enters the legislative queue.

No votes, news coverage, or related bills recorded for this bill yet.

Source Information

Document Type

Congressional Bill

Official Title

John W. Walsh Alpha-1 Home Infusion Act of 2025

Bill NumberHR 2343

Congress119th Congress

ChamberHouse of Representatives

Latest ActionReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Data Sources

Congress.gov

Official legislative information

Read Full Bill Text

Sponsor

Cosponsors

(50)

D: 30R: 20

Analysis generated by AI. Always verify with official sources.